05:36 PM EDT, 03/13/2026 (MT Newswires) -- Thomas Andrew Rowland, Senior Vice President, Head, Established Brands, on March 11, 2026, sold 4,772 shares in Ani Pharmaceuticals ( ANIP ) for $357,471. Following the Form 4 filing with the SEC, Rowland has control over a total of 38,730 common shares of the company, with 38,730 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1023024/000150749626000009/xslF345X05/wk-form4_1773437312.xml